[1]张镛镛,王　芳,雷利娜,等.血清高迁移率族蛋白A2、糖链抗原19-9联合ROMA指数对卵巢癌的诊断价值[J].新乡医学院学报,2020,37(5):471-474.[doi:10.7683/xxyxyxb.2020.05.17]
　ZHANG Yongyong,WANG Fang,LEI Lina,et al.Diagnostic value of serum high mobility group protein A2,carbohydrate antigen 19-9 and ROMA index in ovarian cancer[J].Journal of Xinxiang Medical University,2020,37(5):471-474.[doi:10.7683/xxyxyxb.2020.05.17]
点击复制

血清高迁移率族蛋白A2、糖链抗原19-9联合ROMA指数对卵巢癌的诊断价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年5
页码:
471-474
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Diagnostic value of serum high mobility group protein A2,carbohydrate antigen 19-9 and ROMA index in ovarian cancer
作者:
张镛镛1; 王　芳2; 雷利娜1; 薛秀珍1
（1.河南科技大学第一附属医院妇产科，河南　洛阳　471000；2.郑州大学第二附属医院妇产科，河南　郑州　450000）
Author(s):
ZHANG Yongyong1; WANG Fang2; LEI Lina1; XUE Xiuzhen1
(1.Department of Obstetrics and Gynecology,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,Henan Province,China;2.Department of Obstetrics and Gynecology,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,Henan Province,China)
关键词:
卵巢癌; 高迁移率族蛋白A2; 糖链抗原19-9; ROMA指数; 诊断价值
Keywords:
ovarian cancer; high mobility group protein A2; carbohydrate antigen 19-9; ROMA index; diagnostic value
分类号:
R737.3
DOI:
10.7683/xxyxyxb.2020.05.17
文献标志码:
A
摘要:
目的　探讨高迁移率族蛋白A2（HMGA2）、糖链抗原19-9（CA19-9）联合ROMA指数对卵巢癌的诊断价值。方法　选择2016年3月至2018年3月于河南科技大学第一附属医院行卵巢切除术患者98例为研究对象，其中卵巢癌患者46例（卵巢癌组），良性卵巢疾病患者52例（良性卵巢疾病组）；另选择同期体检健康女性50例为健康对照组。采用酶联免疫吸附试验检测受试者血清CA19-9和HMGA2水平，采用全自动电化学发光仪检测血清人附睾蛋白4和糖链抗原125水平，并计算ROMA指数，采用受试者工作特征（ROC）曲线分析血清CA19-9、HMGA2及ROMA指数对卵巢癌的诊断价值。结果　卵巢癌组患者血清HMGA2、CA19-9水平和ROMA指数均高于良性卵巢疾病组和健康对照组（P＜0.05）；良性卵巢疾病组血清HMGA2、CA19-9水平和ROMA指数高于健康对照组（P＜0.05）。血清CA19-9、HMGA2水平及ROMA指数与卵巢癌国际妇产科协会分期、淋巴结转移有关（P＜0.05），与患者年龄、腹水量及卵巢癌组织学类型无关（P＞0.05）。ROC曲线分析显示，血清CA19-9、HMGA2及ROMA指数对卵巢癌的最佳诊断截断点分别为301.76 kU·L-1、294.13 mg·L-1、82.48%；血清CA19-9、HMGA2及ROMA指数单独检测诊断卵巢癌的特异性、敏感性、准确度比较差异无统计学意义（P＞0.05）；血清CA19-9、HMGA2及ROMA指数联合检测诊断卵巢癌的特异性、敏感性、准确度高于三者单独检测（P＜0.05）。结论　血清HMGA2、CA19-9及ROMA指数联合检测对卵巢癌有一定的诊断价值。
Abstract:
Objective　To investigate the diagnostic value of high mobility group protein A2 (HMGA2),carbohydrate antigen 19-9 (CA19-9) and ROMA index in ovarian cancer.Methods　A total of 98 patients who underwent oophorectomy in the First Affiliated Hospital of Henan University of Science and Technology from March 2016 to March 2018 were selected as the study objects,including 46 cases of ovarian cancer (ovarian cancer group) and 52 cases of benign ovarian diseases (benign ovarian disease group).Another 50 healthy women in the same period were selected as the healthy control group.The serum CA19-9 and HMGA2 levels were detected by enzyme-linked immunosorbent assay,the levels of serum human epididymal protein 4 and carbohydrate antigen 125 were detected by automatic electrochemiluminescence apparatus,and the ROMA index was calculated.The diagnostic value of serum CA19-9,HMGA2 and ROMA index in ovarian cancer was analyzed by receiver operating characteristic (ROC) curve.Results　The levels of serum HMGA2,CA19-9 and ROMA index in the ovarian cancer group were higher than those in the benign ovarian disease group and healthy control group (P＜0.05).The levels of serum HMGA2,CA19-9 and ROMA index in the benign ovarian disease group were higher than those in the healthy control group (P＜0.05).The levels of serum CA19-9,HMGA2 and ROMA index were related to federation international of gynecology and obstetrics staging and lymph node metastasis of ovarian cancer (P＜0.05),but they were not related to the age,ascites volume of the patients and histological type of ovarian cancer (P>0.05).ROC curve analysis showed that the best cut-off points of the serum CA19-9,HMGA2 levels and ROMA index were 301.76 kU·L-1,294.13 mg·L-1 and 82.48%,respectively.There was no significant difference in the specificity,sensitivity and accuracy of the separately detection of serum CA19-9,HMGA2 and ROMA index in the diagnosis of ovarian cancer (P>0.05).The specificity,sensitivity and accuracy of the combined detection of serum CA19-9,HMGA2 and ROMA index in the diagnosis of ovarian cancer were higher than those of the separately detection of them (P＜0.05).Conclusion　The combined detection of serum HMGA2,CA19-9 and ROMA index has certain diagnostic value for ovarian cancer.

参考文献/References:

［1］　REID B M,PERMUTH J B,SELLERS T A.Epidemiology of ovarian cancer:a review［J］.Cancer Biol Med,2017,14(1):9-32．
［2］　仝玉珠.腹腔镜下全面分期手术治疗早期卵巢癌疗效观察［J］．新乡医学院学报，2018，35（9）：804-806．
［3］　AGOSTINI A,BRUNETTI M,DAVIDSON B,et al.Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors:implications for HMGA2 expression［J］.Oncotarget,2017,8(13):21554-21560．
［4］　王春阳，王羽，王子龙，等．血清HE4 TK1 CA199联合检测对卵巢癌的诊断价值［J］．河北医学，2019，25（7）：1081-1085.
［5］　马美英，张广礼，李莉．HE4、CA125及ROMA指数在早期浆液性卵巢癌诊断中的价值［J］．肿瘤学杂志，2018，24（1）：74-76．
［6］　COBURN S B,BRAY F,SHERMAN M E,et al.International patterns and trends in ovarian cancer incidence,overall and by histologic subtype［J］.Int J Cancer,2017,140(11):2451-2460．
［7］　ORONSKY B,RAY C M,SPIRA A I,et al.A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer［J］.Med Oncol,2017,34(6):103-106．
［8］　畅华，张雪，李白雪，等．血清HE4、CA125、ROMA联合检测在上皮性卵巢癌诊断中的应用［J］． 现代肿瘤医学，2018，249（15）：2434-2436．
［9］　陈鹏，郭桂林，张燕菲，等．血清CA125联合HE4及卵巢恶性肿瘤风险算法指数在诊断绝经前后卵巢癌中的价值［J］．中国妇幼保健，2017，32（22）：49-51．
［10］　马丽娟，尹娟，周恩，等．miRNAlet-7a调控HMGA2表达抑制喉癌细胞增殖并促进其凋亡的作用机制［J］．现代肿瘤医学，2018，26（1）：1993-1997．
［11］　ZHAO W,GENG D,LI S,et al.LncRNA HOTAIR influences cell growth,migration,invasion,and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer［J］.Cancer Med,2018,7(3):842-855．
［12］　CHANG H Y,YE S P,PAN S L,et al.Overexpression of miR-194 reverses HMGA2-driven signatures in colorectal cancer［J］.Theranostics,2017,7(16):3889-3900．
［13］　杨静，张旗，董建强，等.高迁移率蛋白A2在浆液性卵巢癌中高表达及其与let-7家族microRNA的关系［J］.北京大学学报（医学版），2012，44（5）：749-754.
［14］　邓艳蕾，赵琴，李明明.miR-129通过靶向调控HMGA2抑制卵巢癌细胞侵袭迁移的作用机制［J］．临床与病理杂志，2018，38（11）：56-63．
［15］　LIU W,LIU Q,WANG W,et al.Differential diagnostic roles of the serum CA19-9,total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant［J］.J Cancer,2018,9(10):1804-1812．
［16］　郑旭，邱雄，邵泽勇，等.胰腺癌患者血清CEMIP、CA19-9和CA242水平变化及其临床意义［J］．实用肝脏病杂志，2019，22（2）：280-284．
［17］　高全霞，杨贵岚，张立欣，等．CA19-9、HE4、CEA联合超声造影诊断卵巢癌的价值［J］．中国妇幼保健，2018，33（10）：2369-2372．
［18］　赖有行．血清HE4、CA125、ROMA指数在卵巢癌患者中的诊断价值［J］．中国妇幼保健，2018，32（1）：48-50．
［19］　王丹，代晶，潘长清，等．血清CA125、HE4以及ROMA指数在卵巢癌早期诊断中的应用价值［J］．实用妇产科杂志，2018，34（4）：80-82．
［20］　郑小妹，陈曼玲.SMRP、ANGPTL3联合ROMA指数诊断上皮性卵巢癌的临床分析［J］.中国现代医学杂志，2018，28（2）：91-94．

相似文献/References:

[1]图妮沙古丽·阿卜拉江,艾星子·艾里,丁岩,等.卵巢癌早期诊断相关因子研究进展[J].新乡医学院学报,,():000.
[2]袁源.血清糖链抗原125和人附睾分泌蛋白4联合检测在卵巢癌诊断中的价值[J].新乡医学院学报,2012,29(11):850.
[3]韩碧波,魏海东,郑　磊,等.经阴道彩色多普勒超声联合血清糖链抗原125和人附睾蛋白4水平检测对卵巢癌的诊断价值[J].新乡医学院学报,2019,36(10):971.[doi:10.7683/xxyxyxb.2019.10.016]
　HAN Bi-bo,WEI Hai-dong,ZHENG Lei,et al.Diagnostic value of transvaginal color Doppler sonography combined with serum carbohydrate antigen 125 and human epididymis protein 4 in ovarian cancer[J].Journal of Xinxiang Medical University,2019,36(5):971.[doi:10.7683/xxyxyxb.2019.10.016]
[4]路　娜,王炳淑,古吉敏.卵巢癌组织中带状疱疹透明带样结构域蛋白1 mRNA表达与肿瘤增殖、侵袭及自噬相关基因表达的相关性[J].新乡医学院学报,2019,36(10):958.[doi:10.7683/xxyxyxb.2019.10.013]
　LU Na,WANG Bing-shu,GU Ji-min.Correlation between the expression of CUB and zona pellucida-like domains-containing protein 1 mRNA and the expression of genes related to proliferation,invasion and autophagy in ovarian cancer tissues[J].Journal of Xinxiang Medical University,2019,36(5):958.[doi:10.7683/xxyxyxb.2019.10.013]
[5]王黎伟,王志芬,孔丽茹,等.超声造影联合血清基质细胞衍生因子-1和磷酸化应激诱导蛋白1检测对卵巢癌的诊断价值[J].新乡医学院学报,2021,38(5):481.[doi:10.7683/xxyxyxb.2021.05.018]
　WANG Liwei,WANG Zhifen,KONG Liru,et al.Diagnostic value of contrast-enhanced ultrasound combined with serum stromal cell-derived factor-1 and stress-induced phosphoprotein 1 for ovarian cancer[J].Journal of Xinxiang Medical University,2021,38(5):481.[doi:10.7683/xxyxyxb.2021.05.018]
[6]于　鹤,刘光新.新辅助化学治疗联合肿瘤细胞减灭术治疗晚期卵巢癌疗效观察[J].新乡医学院学报,2020,37(3):258.[doi:10.7683/xxyxyxb.2020.03.014]
　YU He,LIU Guangxin.Effect of neoadjuvant chemotherapy combined with cytoreductive surgery in the treatment of advanced ovarian cancer[J].Journal of Xinxiang Medical University,2020,37(5):258.[doi:10.7683/xxyxyxb.2020.03.014]
[7]豆秋彦,冯　文,李春霖.脂肪因子chemerin在女性常见恶性肿瘤中的作用研究进展[J].新乡医学院学报,2020,37(12):1195.[doi:10.7683/xxyxyxb.2020.12.021]
[8]仝玉珠.腹腔镜下全面分期手术治疗早期卵巢癌疗效观察[J].新乡医学院学报,2018,35(9):804.[doi:10.7683/xxyxyxb.2018.09.013]
　TONG Yu-zhu.Clinical effect of laparoscopic radical staged surgery in the treatment of early ovarian cancer[J].Journal of Xinxiang Medical University,2018,35(5):804.[doi:10.7683/xxyxyxb.2018.09.013]
[9]何社红,薛聪玲.谷胱甘肽转移酶-π与卵巢癌多药耐药的关系[J].新乡医学院学报,2017,34(4):320.[doi:10.7683/xxyxyxb.2017.04.020]
　HE She-hong,XUE Cong-ling.Relationship between glutathione S-transferase-π and multidrug resistance of ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(5):320.[doi:10.7683/xxyxyxb.2017.04.020]
[10]何社红,薛聪玲.蛋白激酶C活性与卵巢癌多药耐药性的相关性[J].新乡医学院学报,2017,34(7):660.[doi:10.7683/xxyxyxb.2017.07.029]
　HE She-hong,XUE Cong-ling.Correlation between protein kinase C activity and multidrug resistance in ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(5):660.[doi:10.7683/xxyxyxb.2017.07.029]

更新日期/Last Update: 2020-05-05